← SynDRA

METHSUXIMIDE

SynDRA canonical compound SYN0001464 — structure-anchored drug synonym record

All known targets

• CACNA1G
• CACNA1H
• CACNA1I

Mechanisms of action (all sources)

• CACNA1H BLOCKER
• Voltage-gated T-type calcium channel blocker
• CACNA1G BLOCKER
• CACNA1I BLOCKER
• T-type calcium channel blocker

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

• ADORA1
• ADORA2A
• HTR2A
• HTR2B
• HTR2C
• HTR3A
• KCNH2
• MAOA
• MC3R
• MC4R
• MLNR
• NPY1R
• NR1I2
• NR3C1
• OPRD1
• OPRK1
• OPRM1
• PDE3A
• PDE4D
• PGR
• PTGS2
• SLC29A1
• SLC6A2
• SLC6A3
• SLC6A4
• HTR1A
• HRH2
• HRH1
• BDKRB2
• ADORA3
• ADRA1A
• ADRA2A
• ADRA2B
• ADRA2C
• ADRB1
• ADRB2
• AGTR1
• AVPR1A
• AVPR2
• CCKAR

Drug classes

• Anticonvulsants
• Central Nervous System Agents
• Anti-epileptic Agent

ATC classes

• N03A · ANTIEPILEPTICS

Cross-references

• PubChem CID: 6476
• ChEMBL: CHEMBL697
• DrugBank: DB05246
• ChEBI: CHEBI:6846
• KEGG: D00404
• RxNorm: 47858
• Wikipedia: Mesuximide
• TTD: D08EOD

Synonyms

• CELONTIN
• Celontin
• mesuximid
• celontin
• mesuximide
• mesuximidum
• methsuximid
• racemic methsuximide
• (+/-)-Mesuximide
• Mesuximide
• Mesuximida
• NSC-760075
• Mesuximid
• Mesuximidum
• Methsuximid
• Metosuccimmide
• Metsuccimide
• Petinutin
• Methsuximide [BAN]
• Metosuccimmide [DCIT]
• PM 396
• Alpha-Methylphensuximide
• Celontin (TN)
• Mesuximida [INN-Spanish]
• Mesuximide (INN)
• Mesuximidum [INN-Latin]
• Methsuximide (USP)
• Petinutin (TN)
• Alpha-Methyl-alpha-phenyl N-methyl succinimide
• N,2-Dimethyl-2-phenylsuccinimide
• N-Methyl-alpha-methyl-alpha-phenylsuccinimide
• (+-)-N,2-Dimethyl-2-phenylsuccinimide
• 1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine
• 1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione
• 1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione
• 1,3-Dimethyl-3-phenylsuccinimide
• 1,3-dimethyl-3-phenylpyrrolidine-2,5-dione

Reported adverse events

• Proteinuria
• Stevens-Johnson syndrome